BEAM:NASDAQ
Beam Therapeutics Inc
၂၀.၉၀ US$
arrow_downward
-၀.၁၉%(-၀.၀၄၀) 1D
၂၁.၆၆ US$
arrow_upward
+၃.၆၅% (+၀.၇၆)bedtimeAfter hours
Closed: နို ၂၀, GMT-၅ ၁၆:၀၀:၀၂ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
၂၀.၆၀ US$
High
၂၂.၁၀ US$
Low
၂၀.၅၄ US$
Mkt. cap
၂၁၆.၃၁ ဋေ
Avg. vol.
၂.၁၆ သန်း
Volume
၃.၈၉ သန်း
52-wk high
၃၈.၂၆ US$
52-wk low
၂၀.၃၉ US$
EPS
-၁.၀၀ US$
Beta
၂.၂၃
Shares outstanding
၁၀.၃၅ ကုဋေ
No. of employees
၅၅၇
Open
၂၀.၆၀ US$
High
၂၂.၁၀ US$
Low
၂၀.၅၄ US$
Mkt. cap
၂၁၆.၃၁ ဋေ
Avg. vol.
၂.၁၆ သန်း
Volume
၃.၈၉ သန်း
52-wk high
၃၈.၂၆ US$
52-wk low
၂၀.၃၉ US$
EPS
-၁.၀၀ US$
Beta
၂.၂၃
Shares outstanding
၁၀.၃၅ ကုဋေ
No. of employees
၅၅၇
News stories
From web sources and news partners
Investing.com
·
ပြီးခဲ့သည့် ၃၉ မိနစ်
How exposed is the S&P 500 to an AI trade bust?
Bloomberg.com
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 at 5,600? Crushing China’s AI Ambitions Has a Price
Traders Union
·
ပြီးခဲ့သည့် ၅ နာရီ
Ryan Detrick: S&P 500 rose after seven-day losing streak in 16 out of 17 years since 1978
cwibc.co.id
·
ပြီးခဲ့သည့် ၁၆ မိနစ်
S&P 500 Faces Thanksgiving Week After Sharp Market Selloff
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc